BRPI0816571A2 - "composto, processo para preparação do composto, composição farmacêutica, agente e método para o tratamento de uma doença ou uma desordem do sistema nervoso central relacionada à ou afetada pelo recptor 5-ht6" - Google Patents
"composto, processo para preparação do composto, composição farmacêutica, agente e método para o tratamento de uma doença ou uma desordem do sistema nervoso central relacionada à ou afetada pelo recptor 5-ht6"Info
- Publication number
- BRPI0816571A2 BRPI0816571A2 BRPI0816571A BRPI0816571A BRPI0816571A2 BR PI0816571 A2 BRPI0816571 A2 BR PI0816571A2 BR PI0816571 A BRPI0816571 A BR PI0816571A BR PI0816571 A BRPI0816571 A BR PI0816571A BR PI0816571 A2 BRPI0816571 A2 BR PI0816571A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutically acceptable
- compounds
- receptor
- disorder
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2433CH2007 | 2007-10-26 | ||
| PCT/IN2008/000281 WO2009053997A1 (en) | 2007-10-26 | 2008-05-02 | Amino arylsulfonamide compounds and their use as 5-ht6 ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0816571A2 true BRPI0816571A2 (pt) | 2015-12-22 |
Family
ID=39769531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0816571A BRPI0816571A2 (pt) | 2007-10-26 | 2008-05-02 | "composto, processo para preparação do composto, composição farmacêutica, agente e método para o tratamento de uma doença ou uma desordem do sistema nervoso central relacionada à ou afetada pelo recptor 5-ht6" |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7964627B2 (pt) |
| EP (1) | EP2200980B9 (pt) |
| JP (1) | JP5236001B2 (pt) |
| KR (1) | KR101268654B1 (pt) |
| CN (1) | CN101835748B (pt) |
| AT (1) | ATE518833T1 (pt) |
| AU (1) | AU2008315309B2 (pt) |
| BR (1) | BRPI0816571A2 (pt) |
| CA (1) | CA2703157C (pt) |
| CY (1) | CY1112181T1 (pt) |
| DK (1) | DK2200980T3 (pt) |
| EA (1) | EA017154B1 (pt) |
| ES (1) | ES2370680T3 (pt) |
| HK (1) | HK1147750A1 (pt) |
| HR (1) | HRP20110780T2 (pt) |
| IL (1) | IL205231A (pt) |
| MX (1) | MX2010003765A (pt) |
| NZ (1) | NZ585374A (pt) |
| SI (1) | SI2200980T1 (pt) |
| WO (1) | WO2009053997A1 (pt) |
| ZA (1) | ZA201002165B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102153884B (zh) * | 2011-02-16 | 2013-06-19 | 连云港清泰化工有限公司 | 一种墨水型染料及其制备方法与用途 |
| EP3718547A1 (en) | 2011-10-03 | 2020-10-07 | The University of Utah Research Foundation | Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
| CN107261126A (zh) * | 2012-02-02 | 2017-10-20 | 加尔纳根有限责任公司 | 酶组合物及其用于创伤愈合的用途 |
| JP6454346B2 (ja) | 2013-12-20 | 2019-01-16 | サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅ Ｌａｋｅ Ｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． | 芳香族複素環式化合物及び医薬におけるその応用 |
| HUE044011T2 (hu) * | 2014-08-16 | 2019-09-30 | Suven Life Sciences Ltd | 1-[(2-bromofenil) szulfonil]-5-metoxi-3-[(4-metil-1-piperazinil)metil]-1H-indol dimezilát monohidrát aktív metabolitja és az aktív metabolit dimezilát dihidrát sója |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DZ2376A1 (fr) | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
| ATE296811T1 (de) | 1997-07-11 | 2005-06-15 | Smithkline Beecham Plc | Sulfonamid-derivate als 5-ht6 receptor antagonisten und verfahren zu ihrer herstellung |
| DK0930302T3 (da) * | 1998-01-16 | 2003-07-21 | Hoffmann La Roche | Benzosulfonderivater |
| GB9801392D0 (en) | 1998-01-22 | 1998-03-18 | Smithkline Beecham Plc | Novel compounds |
| GB9803411D0 (en) | 1998-02-18 | 1998-04-15 | Smithkline Beecham Plc | Novel compounds |
| ES2291024T4 (es) | 1999-04-21 | 2009-03-01 | Nps Allelix Corp. | Compuestos de piperidina-indol con afinidad con 5-ht6. |
| GB9926302D0 (en) | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
| JP2004526699A (ja) | 2001-01-30 | 2004-09-02 | イーライ・リリー・アンド・カンパニー | ５−ｈｔ６受容体の拮抗薬としてのベンゼンスルホン酸インドール−５−イルエステル類 |
| EP1383767A1 (en) | 2001-02-08 | 2004-01-28 | Memory Pharmaceutical Corporation | Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
| HUP0401307A2 (hu) | 2001-06-07 | 2004-12-28 | F. Hoffmann-La Roche Ag | 5-HT6 hatással rendelkező új indolszármazékok, eljárás az előállításukra, és ezeket tartalmazó gyógyszerkészítmények |
| JP2005528587A (ja) | 2002-02-01 | 2005-09-22 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 新規ヒト５−ｈｔ６受容体に関連する疾患のための診断用および治療用物質 |
| JP2005522432A (ja) | 2002-02-05 | 2005-07-28 | グラクソ グループ リミテッド | ニューロン成長の促進方法 |
| SI1497266T1 (sl) | 2002-03-27 | 2008-10-31 | Glaxo Group Ltd | Derivati kinolina in njihova uporaba kot ligandi 5-ht6 |
| BR0315317A (pt) * | 2002-10-18 | 2005-09-06 | Hoffmann La Roche | 4-piperazinil benzenossulfonil indóis com afinidade para o receptor de 5-ht6 |
| CN1720225B (zh) | 2002-11-28 | 2011-05-18 | 苏文生命科学有限公司 | 具有5-羟色胺受体亲和性的n-芳基磺酰-3-取代吲哚及其制备方法和含有其的药物组合物 |
| EP1567492B1 (en) * | 2002-11-28 | 2013-05-22 | Suven Life Sciences Limited | N-arylsulfonyl-3-aminoalkoxyindoles |
| WO2004048331A1 (en) | 2002-11-28 | 2004-06-10 | Suven Life Sciences Limited | N-arylalkyl-3-aminoalkoxyindoles and their use as 5-ht ligands |
| JP4571507B2 (ja) | 2002-12-18 | 2010-10-27 | スベン ライフ サイエンシズ リミティド | セロトニン受容体親和性を有する四環系３−置換インドール |
| DE602005018554D1 (de) * | 2005-08-12 | 2010-02-04 | Suven Life Sciences Ltd | Aminoarylsulfonamidderivate als funktionelle 5-ht6-liganden |
-
2008
- 2008-05-02 BR BRPI0816571A patent/BRPI0816571A2/pt active Search and Examination
- 2008-05-02 EP EP08776656A patent/EP2200980B9/en active Active
- 2008-05-02 CN CN2008801127356A patent/CN101835748B/zh not_active Expired - Fee Related
- 2008-05-02 DK DK08776656.4T patent/DK2200980T3/da active
- 2008-05-02 JP JP2010530633A patent/JP5236001B2/ja active Active
- 2008-05-02 AT AT08776656T patent/ATE518833T1/de active
- 2008-05-02 WO PCT/IN2008/000281 patent/WO2009053997A1/en active Application Filing
- 2008-05-02 CA CA2703157A patent/CA2703157C/en not_active Expired - Fee Related
- 2008-05-02 ES ES08776656T patent/ES2370680T3/es active Active
- 2008-05-02 KR KR1020107010395A patent/KR101268654B1/ko active IP Right Grant
- 2008-05-02 MX MX2010003765A patent/MX2010003765A/es active IP Right Grant
- 2008-05-02 SI SI200830420T patent/SI2200980T1/sl unknown
- 2008-05-02 EA EA201070527A patent/EA017154B1/ru not_active IP Right Cessation
- 2008-05-02 AU AU2008315309A patent/AU2008315309B2/en not_active Ceased
- 2008-05-02 NZ NZ585374A patent/NZ585374A/en not_active IP Right Cessation
- 2008-05-02 US US12/682,596 patent/US7964627B2/en not_active Expired - Fee Related
-
2010
- 2010-03-26 ZA ZA2010/02165A patent/ZA201002165B/en unknown
- 2010-04-21 IL IL205231A patent/IL205231A/en active IP Right Grant
-
2011
- 2011-02-25 HK HK11101861.1A patent/HK1147750A1/xx not_active IP Right Cessation
- 2011-10-26 HR HRP20110780TT patent/HRP20110780T2/hr unknown
- 2011-11-03 CY CY20111101058T patent/CY1112181T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008315309B2 (en) | 2011-06-09 |
| NZ585374A (en) | 2011-09-30 |
| ZA201002165B (en) | 2011-05-25 |
| ES2370680T9 (es) | 2012-02-15 |
| EP2200980B1 (en) | 2011-08-03 |
| CA2703157A1 (en) | 2009-04-30 |
| CY1112181T1 (el) | 2015-12-09 |
| ES2370680T3 (es) | 2011-12-21 |
| HRP20110780T1 (en) | 2011-11-30 |
| MX2010003765A (es) | 2010-04-30 |
| HRP20110780T2 (hr) | 2018-06-29 |
| US7964627B2 (en) | 2011-06-21 |
| SI2200980T1 (sl) | 2011-12-30 |
| IL205231A0 (en) | 2010-12-30 |
| KR20100069707A (ko) | 2010-06-24 |
| EP2200980B9 (en) | 2011-12-28 |
| JP5236001B2 (ja) | 2013-07-17 |
| EA017154B1 (ru) | 2012-10-30 |
| JP2011500792A (ja) | 2011-01-06 |
| IL205231A (en) | 2014-03-31 |
| DK2200980T3 (da) | 2011-11-21 |
| WO2009053997A1 (en) | 2009-04-30 |
| AU2008315309A1 (en) | 2009-04-30 |
| CA2703157C (en) | 2013-02-05 |
| HK1147750A1 (en) | 2011-08-19 |
| ATE518833T1 (de) | 2011-08-15 |
| EP2200980A1 (en) | 2010-06-30 |
| US20100216861A1 (en) | 2010-08-26 |
| KR101268654B1 (ko) | 2013-05-29 |
| EA201070527A1 (ru) | 2010-10-29 |
| CN101835748A (zh) | 2010-09-15 |
| CN101835748B (zh) | 2012-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0309167A (pt) | Composto, processo para a produção de um composto, composição farmacêutica, uso do composto, método para o tratamento de um sujeito afetado por uma condição patológica ou doença e produto de combinação | |
| BRPI0409109A (pt) | novos compostos | |
| BR0312216A (pt) | Composto, processo para a produção de um composto, composição farmacêutica, uso do composto, método para o tratamento de um sujeito que sofre de uma doença ou condição patológica e combinação de produto | |
| BR0207526A (pt) | Composto, composição farmacêutica, e, métodos para o tratamento da dor, da enxaqueca, depressão, ansiedade, esquizofrenia, doença de parkinson ou derrame cerebral | |
| MA32898B1 (fr) | Modulateurs allosteriques positifs du recepteur m1 d'arylmethylbenzoquinazolinone | |
| MX2010004026A (es) | Piperidino-dihidrotienopirimidinas sustituidas. | |
| JO2686B1 (en) | Vehicles | |
| SE0301009D0 (sv) | Novel compounds | |
| MY147677A (en) | Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases | |
| BRPI0417376A (pt) | compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com a modulação de receptores de cb1 e sua utilização | |
| UA84048C2 (ru) | Производные сульфонамида для лечения заболеваний, способ их получения (варианты), фармацевтическая композиция на их основе | |
| BRPI0508051A (pt) | derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes | |
| BR112012003464B8 (pt) | compostos de piranil aril metil benzoquinaozlinona, uso dos mesmos, e, composição farmacêutica | |
| WO2009025785A3 (en) | Cb2 receptor ligands for the treatment of pain | |
| TW200630336A (en) | Novel compounds | |
| DE502005010170D1 (de) | Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel | |
| TW200621690A (en) | Novel compounds | |
| EA200801302A1 (ru) | Композиции и способы лечения нарушений цнс | |
| BRPI0816571A2 (pt) | "composto, processo para preparação do composto, composição farmacêutica, agente e método para o tratamento de uma doença ou uma desordem do sistema nervoso central relacionada à ou afetada pelo recptor 5-ht6" | |
| BRPI0510501A (pt) | antagonistas do receptor 3 de histamina | |
| MEP42908A (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds | |
| BRPI0809873A2 (pt) | "composto, processo para a preparação do composto, método para o tratamento de uma desordem do sistema nervoso central, composição farmacêutica, uso do composto, método para testar antagonistas e antagonistas com seletividade para o receptor 5-th6 e método de tratamento" | |
| BRPI0507120A (pt) | compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com a modulação de receptores de cb1 e sua utilização | |
| ATE523488T1 (de) | Histamin-h3-rezeptor-mittel, deren herstellung und therapeutische verwendung | |
| BRPI0509515A (pt) | composto, formulação farmacêutica, uso de um composto método para tratamento de doenças, e, processo para a preparação de um composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |